Jon Carl Serbousek net worth and biography

Jon Serbousek Biography and Net Worth

Mr. Serbousek joined Orthofix in August 2019 and became director, President and CEO in November 2019. A seasoned executive with more than 30 years’ experience in the medical device and biotech industries, Mr. Serbousek served in several leadership positions at Biomet Inc., including Worldwide President of Biomet Biologics, Worldwide Group President of Orthopedics, and President of U.S. Orthopedics. Prior to joining Biomet, he held various general management positions within Medtronic Inc., including Worldwide Division President − Spine, and Worldwide Vice President and General Manager of Biologics for their Spine and Biologics business. Additionally, Mr. Serbousek spent 13 years with DePuy Orthopedics, a Johnson & Johnson company where he served in numerous roles of increasing responsibility, including Vice President of Marketing and Product Development and Vice President of Spinal Operations. Mr. Serbousek has held numerous board positions at for profit and not-for-profit organizations. He earned his BS in Engineering from Washington State University, his MS in Bioengineering from the University of Utah, and later completed several advanced management programs including a program at the IMD International School of Management in Lausanne, Switzerland.

What is Jon Carl Serbousek's net worth?: The estimated net worth of Jon Carl Serbousek is at least $545,802.24 as of February 27th, 2020. Mr. Serbousek owns 41,728 shares of Orthofix Medical stock worth more than $545,802 as of April 23rd. This net worth estimate does not reflect any other investments that Mr. Serbousek may own. Learn More about Jon Carl Serbousek's net worth.
How do I contact Jon Carl Serbousek?: The corporate mailing address for Mr. Serbousek and other Orthofix Medical executives is 3451 Plano Parkway, Lewisville TX, 75056. Orthofix Medical can also be reached via phone at (214) 937-2000 and via email at [email protected]. Learn More on Jon Carl Serbousek's contact information.
Has Jon Carl Serbousek been buying or selling shares of Orthofix Medical?: Jon Carl Serbousek has not been actively trading shares of Orthofix Medical during the last ninety days. Most recently, on Thursday, November 18th, Jon Carl Serbousek bought 1,670 shares of Orthofix Medical stock. The stock was acquired at an average cost of $31.14 per share, with a total value of $52,003.80. Learn More on Jon Carl Serbousek's trading history.
Who are Orthofix Medical's active insiders?: Orthofix Medical's insider roster includes Catherine Burzik (Director), Rice Doug (CFO), Kimberley Elting (Insider), Michael Paolucci (Director), and Jon Serbousek (CEO). Learn More on Orthofix Medical's active insiders.
Are insiders buying or selling shares of Orthofix Medical?: In the last year, Orthofix Medical insiders bought shares 1 times. They purchased a total of 7,500 shares worth more than $101,025.00. In the last year, insiders at the medical device company sold shares 2 times. They sold a total of 8,243 shares worth more than $156,617.00. The most recent insider tranaction occured on September, 14th when Director James F Hinrichs bought 7,500 shares worth more than $101,025.00. Insiders at Orthofix Medical own 4.7% of the company. Learn More about insider trades at Orthofix Medical.
Information on this page was last updated on 9/14/2023.

Jon Carl Serbousek Insider Trading History at Orthofix Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/18/2021	Buy	1,670	$31.14	$52,003.80
2/27/2020	Buy	2,900	$35.48	$102,892.00	41,728

Jon Carl Serbousek Buying and Selling Activity at Orthofix Medical

Orthofix Medical Company Overview

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Today's Range

Now: $13.08

$12.82

$13.32

50 Day Range

MA: $13.72

$13.00

$14.64

2 Week Range

Now: $13.08

$9.57

$21.60

Volume

275,511 shs

Average Volume

407,470 shs

Market Capitalization

$489.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report